Abstract
It was suggested from this study that in some chronic hemodialysis patients hyperlipidemia was gradually developed according to longterm hemodialysis therapy and thus atherosclerotic vascular disease was accelerated.
Chronic hemodialysis patients have hyperlipidemia which sometimes is resistant to drug therapy. LDL reduction therapy was supposed to be clinically effective in regression of atherosclerotic symp-toms in chronic hemodialysis patients with hyperlipidemia. LDL adsorption with hemodialysis is an effective and safe procedure to treat hyperlipidemia in chronic hemodialysis patients. Ultimately LDL reduction could reduce the increase of atherosclerosis and coronary artery disease in this population.
